Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

被引：0
|
作者：
Sumiyoshi, Y.
Hashine, K.
Niwakawa, M.
Yamaguchi, R.
Fujii, H.
Hamamoto, Y.
Fukino, K.
机构：
[1] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[2] Shizuoka Canc Ctr Hosp, Shizuoka, Japan
[3] Jichi Med Univ, Tochigi, Japan
[4] Tochigi Canc Ctr Hosp, Tochigi, Japan
[5] Bayer Yakuhin, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16107
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
    Masashi Niwakawa
    Katsuyoshi Hashine
    Raizo Yamaguchi
    Hirofumi Fujii
    Yasuo Hamamoto
    Koichi Fukino
    Takahiko Tanigawa
    Yoshiteru Sumiyoshi
    Investigational New Drugs, 2012, 30 : 1046 - 1054
  • [2] Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
    Niwakawa, Masashi
    Hashine, Katsuyoshi
    Yamaguchi, Raizo
    Fujii, Hirofumi
    Hamamoto, Yasuo
    Fukino, Koichi
    Tanigawa, Takahiko
    Sumiyoshi, Yoshiteru
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1046 - 1054
  • [3] Erratum to: Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma
    Masashi Niwakawa
    Katsuyoshi Hashine
    Raizo Yamaguchi
    Hirofumi Fujii
    Yasuo Hamamoto
    Koichi Fukino
    Takahiko Tanigawa
    Yoshiteru Sumiyoshi
    Investigational New Drugs, 2012, 30 (3) : 1274 - 1275
  • [4] Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
    Eto, Masatoshi
    Kawano, Yoshiaki
    Hirao, Yoshihiko
    Mita, Koji
    Arai, Yoichi
    Tsukamoto, Taiji
    Hashine, Katsuyoshi
    Matsubara, Akio
    Fujioka, Tomoaki
    Kimura, Go
    Shinohara, Nobuo
    Tatsugami, Katsunori
    Hinotsu, Shiro
    Naito, Seiji
    BMC CANCER, 2015, 15
  • [5] Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan
    Masatoshi Eto
    Yoshiaki Kawano
    Yoshihiko Hirao
    Koji Mita
    Yoichi Arai
    Taiji Tsukamoto
    Katsuyoshi Hashine
    Akio Matsubara
    Tomoaki Fujioka
    Go Kimura
    Nobuo Shinohara
    Katsunori Tatsugami
    Shiro Hinotsu
    Seiji Naito
    BMC Cancer, 15
  • [6] Phase I trial of sorafenib (BAY 43-9006) in combination with interferon alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma and malignant melanoma
    Robert, C.
    Lassau, N.
    Angevin, E.
    Soria, J.
    Chami, L.
    Zarafana, E.
    Landreau, V.
    Schwartz, B.
    Armand, J.
    Escudier, B.
    EJC SUPPLEMENTS, 2005, 3 (02): : 254 - 254
  • [7] Phase I trial of sorafenib in combination with IFN α-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma
    Escudier, Bernard
    Lassau, Nathalie
    Angevin, Eric
    Soria, Jean Charles
    Chami, Linda
    Lamuraglia, Michele
    Zafarana, Eric
    Landreau, Veronique
    Schwartz, Brian
    Brendel, Eric
    Armand, Jean-Pierre
    Robert, Caroline
    CLINICAL CANCER RESEARCH, 2007, 13 (06) : 1801 - 1809
  • [8] EXTENDED ANALYSES OF PHASE II CLINICAL TRIAL OF SORAFENIB PLUS INTERFERON-ALPHA TREATMENT FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN JAPAN
    Eto, Masatoshi
    Kawano, Yoshiaki
    Hirao, Yoshihiko
    Mita, Koji
    Arai, Yoichi
    Tsukamoto, Taiji
    Hashine, Katsuyoshi
    Matsubara, Akio
    Fujioka, Tomoaki
    Kimura, Go
    Shinohara, Nobuo
    Tatsugami, Katsunori
    Hinotsu, Shiro
    Naito, Seiji
    JOURNAL OF UROLOGY, 2015, 193 (04): : E874 - E874
  • [9] Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma
    Clark, PE
    Hall, MC
    Miller, A
    Ridenhour, KP
    Stindt, D
    Lovato, JF
    Patton, SE
    Brinkley, W
    Das, S
    Torti, FM
    UROLOGY, 2004, 63 (06) : 1061 - 1065
  • [10] Phase I trial of capecitabine and subcutaneous interferon-alpha in renal cell carcinoma (RCC)
    Bukowski, RM
    Olencki, T
    Bocock, K
    Budd, GT
    Peereboom, D
    McLain, D
    Griffin, T
    ANNALS OF ONCOLOGY, 1998, 9 : 120 - 120
12345